{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:33:36Z","timestamp":1787009616644,"version":"build-2736575974"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T00:00:00Z","timestamp":1603584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Major International (Regional) Joint Research Project","award":["81720108020"],"award-info":[{"award-number":["81720108020"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC0909003"],"award-info":[{"award-number":["2017YFC0909003"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Program of National Natural Science Foundation of China","award":["81930043"],"award-info":[{"award-number":["81930043"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the association and dose\u2013response pattern between antimalarial drugs and overall and cause specific mortality in SLE patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records including information on HCQ\/chloroquine (CQ) prescription were extracted from Jiangsu Lupus database. The database was designed to collect data from SLE patients that first-hospitalized during 1999\u20132009 in Jiangsu province, China, and a follow-up for survival status was performed in 2010 and 2015. Cox and restricted cubic spline models were used to estimate the hazard ratio and 95% CI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 221 deaths among 2446 SLE patients in total. Compared with non-users, decreased overall mortality was associated with either HCQ or CQ users, with adjusted hazard ratio (95% CI) of 0.49 (0.35, 0.67) and 0.49 (0.27, 0.87), respectively. The association between HCQ\/CQ and overall mortality was similar across subgroups, such as patients with comorbidities and organ involvements. Interestingly, both the time and the daily dosage of HCQ\/CQ use were related to decreased mortality of SLE in a linear dose\u2013response relationship. In cause specific analyses, HCQ\/CQ was inversely associated with death from renal insufficiency and other organ (cardiopulmonary, gastrointestinal and haematological) involvements, with adjusted hazard ratio (95% CI) of 0.23 (0.09, 0.55) and 0.25 (0.10, 0.62), respectively, yet it was not significantly associated with mortality from infection and neuropsychiatric involvements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Antimalarial drugs were associated with lower risk of SLE mortality, especially renal insufficiency- and other organ involvement-related death. The protective effects for survival might be augmented by adherence and full dosage of these drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa485","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T07:31:14Z","timestamp":1594798274000},"page":"1774-1783","source":"Crossref","is-referenced-by-count":23,"title":["Association of antimalarial drugs with decreased overall and cause specific mortality in systemic lupus erythematosus"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-2266","authenticated-orcid":false,"given":"Ziyi","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyou","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Huai\u2019an First People\u2019s Hospital, Huai\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Xuzhou Central Hospital, Xuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The Third Affiliated Hospital of Soochow University, Changzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixia","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lianyungang Second People\u2019s Hospital, Lianyungang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lianyungang First People\u2019s Hospital, Lianyungang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Northern Jiangsu People\u2019s Hospital, Yangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohong","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Wuxi People\u2019s Hospital, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Jiangsu Province Hospital of TCM, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Southeast University Zhongda Hospital, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, The First Affiliated Hospital of Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Wuxi TCM Hospital, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Zhenjiang First People\u2019s Hospital, Zhenjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanyun","family":"Da","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Nantong University, Nantong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Affiliated Hospital of Jiangsu University, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,25]]},"reference":[{"key":"2021040620373017200_keaa485-B1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.semarthrit.2011.11.002","article-title":"Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s","volume":"41","author":"Mak","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"2021040620373017200_keaa485-B2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"Yurkovich","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620373017200_keaa485-B3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/acr.20683","article-title":"Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality","volume":"64","author":"Jakes","year":"2012","journal-title":"Arthritis Care Res (Hoboken"},{"key":"2021040620373017200_keaa485-B4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021040620373017200_keaa485-B5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/acr.22837","article-title":"Hydroxychloroquine serum concentrations and flares of systemic lupus erythematosus: a longitudinal cohort analysis","volume":"68","author":"Mok","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620373017200_keaa485-B6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2147\/DDDT.S166893","article-title":"Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis","volume":"12","author":"Liu","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"2021040620373017200_keaa485-B7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.24538","article-title":"Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort","volume":"61","author":"Pons-Estel","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2021040620373017200_keaa485-B8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021040620373017200_keaa485-B9","first-page":"395","article-title":"Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City","volume":"19","author":"Hernandez-Cruz","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620373017200_keaa485-B10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"2021040620373017200_keaa485-B11","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)","volume":"66","author":"Alarcon","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021040620373017200_keaa485-B12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0961203307086503","article-title":"Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival","volume":"17","author":"Siso","year":"2008","journal-title":"Lupus"},{"key":"2021040620373017200_keaa485-B13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/art.27300","article-title":"Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort","volume":"62","author":"Shinjo","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021040620373017200_keaa485-B14","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s10067-017-3735-1","article-title":"Survival analysis of patients with systemic lupus erythematosus in a tertiary hospital in southern Brazil","volume":"36","author":"Hendler","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2021040620373017200_keaa485-B15","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/rheumatology\/key167","article-title":"Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus","volume":"57","author":"Hsu","year":"2018","journal-title":"Rheumatology (Oxford"},{"key":"2021040620373017200_keaa485-B16","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1136\/annrheumdis-2018-213819","article-title":"Protective effects of antimalarials in Chinese patients with systemic lupus erythematosus","volume":"78","author":"Wang","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2021040620373017200_keaa485-B17","doi-asserted-by":"crossref","first-page":"e0168619","DOI":"10.1371\/journal.pone.0168619","article-title":"Prognosis for hospitalized patients with systemic lupus erythematosus in china: 5-year update of the Jiangsu Cohort","volume":"11","author":"Feng","year":"2016","journal-title":"PLoS One"},{"key":"2021040620373017200_keaa485-B18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3899\/jrheum.101088","article-title":"Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China","volume":"38","author":"Feng","year":"2011","journal-title":"J Rheumatol"},{"key":"2021040620373017200_keaa485-B19","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2021040620373017200_keaa485-B20","first-page":"733","article-title":"Systemic lupus erythematosus disease activity index","volume":"40","author":"Touma","year":"2013","journal-title":"J Rheumatol 2002"},{"key":"2021040620373017200_keaa485-B21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","article-title":"Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis","volume":"15","author":"Kasitanon","year":"2006","journal-title":"Lupus"},{"key":"2021040620373017200_keaa485-B22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0961203319890007","article-title":"Recovery of renal function in patients with lupus nephritis and reduced renal function: the beneficial effect of hydroxychloroquine","volume":"29","author":"Lee","year":"2020","journal-title":"Lupus"},{"key":"2021040620373017200_keaa485-B23","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2021040620373017200_keaa485-B24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0961203319851558","article-title":"Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort","volume":"28","author":"Geraldino-Pardilla","year":"2019","journal-title":"Lupus"},{"key":"2021040620373017200_keaa485-B25","article-title":"The clinical significance of monitoring hydroxychloroquine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis","author":"Garg","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620373017200_keaa485-B26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.semarthrit.2018.01.002","article-title":"Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus","volume":"48","author":"Feldman","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2021040620373017200_keaa485-B27","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cpt.1194","article-title":"A prospective international study on adherence to treatment in 305 patients with flaring SLE: assessment by drug levels and self-administered questionnaires","volume":"106","author":"Costedoat-Chalumeau","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2021040620373017200_keaa485-B28","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10787-018-0498-5","article-title":"Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article","volume":"26","author":"Mascolo","year":"2018","journal-title":"Inflammopharmacology"},{"key":"2021040620373017200_keaa485-B29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/art.39070","article-title":"Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis","volume":"67","author":"Feldman","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021040620373017200_keaa485-B30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3899\/jrheum.150671","article-title":"Risk of serious infection for patients with systemic lupus erythematosus starting glucocorticoids with or without antimalarials","volume":"43","author":"Herrinton","year":"2016","journal-title":"J Rheumatol"},{"key":"2021040620373017200_keaa485-B31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrneph.2011.150","article-title":"The role of antimalarial agents in the treatment of SLE and lupus nephritis","volume":"7","author":"Lee","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2021040620373017200_keaa485-B32","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrrheum.2012.106","article-title":"New insights into mechanisms of therapeutic effects of antimalarial agents in SLE","volume":"8","author":"Wallace","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"2021040620373017200_keaa485-B33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2021040620373017200_keaa485-B34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1067\/mjd.2000.103635","article-title":"Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment","volume":"42","author":"Jewell","year":"2000","journal-title":"J Am Acad Dermatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1774\/36913589\/keaa485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1774\/36913589\/keaa485.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:40:35Z","timestamp":1617738035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/4\/1774\/5939816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,25]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,10,25]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa485","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,10,25]]}}}